We all know the risks of influenza and COVID for older people. But a third virus, RSV, can also land you in hospital. A free ...
Respiratory syncytial virus (RSV) is a common virus that can cause severe respiratory illness in infants and young children, ...
The combined use of nirsevimab and maternal respiratory syncytial virus vaccine is linked to a lower burden of severe RSV infection among infants aged 7 months or younger in Washington state.
The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results